Condition
Clonal Hematopoiesis of Indeterminate Potential clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Clonal Hematopoiesis of Indeterminate Potential clinical trials that are recruiting, at sites in 4 countries (most in United States (3), China (1), Belgium (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Clonal Hematopoiesis of Indeterminate Potential clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Precision colchicine to target atherosclerosis in people with TET2-CHIP after ACS | Phase 4 | Shenyang, Liaoning | Recruiting | Jan 23, 2026 |
| Evaluating the risk of blood cancers in firefighters | — | Charlotte, North Carolina | Recruiting | Mar 11, 2025 |
| Investigating Clonal Hematopoiesis and Neutrophil Extracellular Traps in Venous Thrombosis | — | Bordeaux and 6 other locations | Recruiting | Feb 2, 2023 |
| Analyzing metabolic profiles of blood stem cells in older adults with clonal hematopoiesis | — | Bonheiden, België | Recruiting | Feb 18, 2022 |
| Understanding the natural progression of blood cell disorders | — | Bethesda, Maryland | Recruiting | Sep 25, 2019 |
| Testing genetic markers for early detection of myeloid cancers and bone marrow failure | — | Scottsdale, Arizona and 2 other locations | Recruiting | Nov 8, 2016 |
All recruiting trials (6)
-
Precision colchicine to target atherosclerosis in people with TET2-CHIP after ACS
This study tests whether including colchicine helps post-ACS patients, guided by TET2-CHIP status, to reduce plaque growth.
-
Evaluating the risk of blood cancers in firefighters
This study is testing if firefighters who have been exposed to harmful substances are at a higher risk for blood cancers and related conditions.
-
Investigating Clonal Hematopoiesis and Neutrophil Extracellular Traps in Venous Thrombosis
This study is trying to see if certain blood changes are linked to repeated blood clots in younger people who don’t have the usual risk factors.
-
Analyzing metabolic profiles of blood stem cells in older adults with clonal hematopoiesis
This study is trying to see how aging affects blood stem cells in older adults with certain genetic changes, by looking at blood and bone marrow samples taken during hip surgery.
-
Understanding the natural progression of blood cell disorders
This study is trying to understand how certain blood cell disorders develop over time in adults by looking at their genes and seeing if they are linked to blood cancers and other health issues.
-
Testing genetic markers for early detection of myeloid cancers and bone marrow failure
This study is testing if looking for specific genetic markers in blood and tissue samples can help find myeloid cancers and bone marrow issues earlier in people who show early signs but aren't diagnosed yet.
Related topics
Quick answers
How many Clonal Hematopoiesis of Indeterminate Potential clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), China (1 trial), Belgium (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.